Name | Number of supported studies | Average coverage | |
---|---|---|---|
luminal hormone-sensing cell of mammary gland | 4 studies | 24% ± 6% | |
pancreatic ductal cell | 3 studies | 39% ± 18% |
Insufficient scRNA-seq data for expression of VTCN1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1310.53 | 328 / 328 | 44% | 14.30 | 78 / 178 |
breast | 65% | 2825.34 | 300 / 459 | 78% | 191.79 | 870 / 1118 |
kidney | 97% | 898.58 | 86 / 89 | 11% | 8.29 | 102 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.07 | 1 / 1 |
ovary | 13% | 10.14 | 24 / 180 | 83% | 141.29 | 358 / 430 |
prostate | 71% | 232.19 | 174 / 245 | 7% | 1.70 | 33 / 502 |
bladder | 48% | 171.24 | 10 / 21 | 25% | 19.16 | 128 / 504 |
skin | 64% | 229.46 | 1165 / 1809 | 0% | 0.04 | 1 / 472 |
uterus | 20% | 66.26 | 34 / 170 | 38% | 33.28 | 173 / 459 |
liver | 36% | 33.91 | 82 / 226 | 12% | 23.39 | 50 / 406 |
lung | 13% | 15.95 | 73 / 578 | 30% | 18.74 | 346 / 1155 |
esophagus | 10% | 18.73 | 141 / 1445 | 18% | 8.27 | 33 / 183 |
tonsil | 0% | 0 | 0 / 0 | 13% | 5.81 | 6 / 45 |
stomach | 8% | 6.96 | 30 / 359 | 4% | 0.85 | 12 / 286 |
thymus | 1% | 0.99 | 6 / 653 | 12% | 4.69 | 70 / 605 |
muscle | 9% | 7.86 | 71 / 803 | 0% | 0 | 0 / 0 |
heart | 8% | 6.13 | 72 / 861 | 0% | 0 | 0 / 0 |
intestine | 0% | 0.22 | 1 / 966 | 4% | 1.37 | 21 / 527 |
adipose | 3% | 4.97 | 31 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0.98 | 1 / 258 | 0% | 0 | 0 / 230 |
brain | 0% | 0.14 | 6 / 2642 | 0% | 0 | 0 / 705 |
blood vessel | 0% | 0.45 | 3 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.18 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0002250 | Biological process | adaptive immune response |
GO_0042102 | Biological process | positive regulation of T cell proliferation |
GO_0001562 | Biological process | response to protozoan |
GO_0050868 | Biological process | negative regulation of T cell activation |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0042130 | Biological process | negative regulation of T cell proliferation |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0001817 | Biological process | regulation of cytokine production |
GO_0032743 | Biological process | positive regulation of interleukin-2 production |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | VTCN1 |
Protein name | V-set domain containing T cell activation inhibitor 1 V-set domain-containing T-cell activation inhibitor 1 (B7 homolog 4) (B7-H4) (B7h.5) (Immune costimulatory protein B7-H4) (Protein B7S1) (T-cell costimulatory molecule B7x) |
Synonyms | UNQ659/PRO1291 B7H4 |
Description | FUNCTION: Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells (Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation. . |
Accessions | ENST00000328189.7 [Q7Z7D3-2] ENST00000369458.8 [Q7Z7D3-1] Q5T2L0 Q7Z7D3 ENST00000359008.8 ENST00000539893.5 [Q7Z7D3-4] |